Skip to main content

TurboWorx Moves from New Haven to Burlington, Mass.

NEW YORK, July 21 - Citing the need to "accommodate continued company growth and momentum," TurboWorx said today that it has packed up its New Haven, Conn., offices for new digs in Burlington, Mass.


The new facility is home to TurboWorx' executive, sales and marketing, customer support, and consulting teams - around a dozen employees, according to a company spokeswoman. TurboWorx will also maintain a development office in Shelton, Conn., and a sales and consulting office in Oxford, UK.


TurboWorx moved into the new facility about a month ago, said Karen Tuttle, director of marketing communications for the company. The new office provides "a lot of room for expansion," Tuttle told GenomeWeb, citing customer support and consulting as the company's most likely areas for growth.


TurboWorx took its first steps into Massachusetts in April, when it acquired Worcester-based Argentys (formerly Blackstone Computing).

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.